Investigation of safety and efficacy of the new more thermostable formulation of Flolan (epoprostenol) in Japanese patients with pulmonary arterial hypertension (PAH)—An open-label, single-arm study

• Kazuko Mihara ,

  Roles Conceptualization, Data curation, Investigation, Methodology, Writing – original draft

  * E-mail: kazuko.2.mihara@gsk.com

  Affiliation Medicines Development, GlaxoSmithKline K.K., Tokyo, Japan

  http://orcid.org/0000-0001-9083-3820

  ⨯
• Aiko Ogawa,

  Roles Conceptualization, Data curation, Investigation, Methodology, Writing – review & editing

  Affiliation Department of Clinical Science, National Hospital Organization Okayama Medical Center, Okayama, Japan

  ⨯
• Hiromi Matsubara,

  Roles Conceptualization, Data curation, Investigation, Methodology, Writing – review & editing

  Affiliation Department of Clinical Science, National Hospital Organization Okayama Medical Center, Okayama, Japan

  ⨯
• Takumi Terao,

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – review & editing

  Affiliation Biomedical Data Sciences Department, GlaxoSmithKline K.K., Tokyo, Japan

  ⨯
• Yoshitaka Ichikawa

  Roles Conceptualization, Data curation, Investigation, Methodology, Project administration, Writing – review & editing

  Current address: Clinical Development Group, Research and Development Division, SymBio Pharmaceuticals Limited, Tokyo, Japan

  Affiliation Project Management Department, GlaxoSmithKline K.K., Tokyo, Japan

  ⨯